Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $16.8 Million - $19.2 Million
-133,200 Reduced 81.42%
30,400 $4.16 Million
Q1 2024

May 15, 2024

BUY
$123.78 - $142.11 $4.73 Million - $5.43 Million
38,200 Added 30.46%
163,600 $21.8 Million
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $8.89 Million - $10.4 Million
73,700 Added 142.55%
125,400 $17.3 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $170,604 - $202,887
-1,400 Reduced 2.64%
51,700 $6.3 Million
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $4.53 Million - $5.1 Million
-34,700 Reduced 39.52%
53,100 $7.46 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $18.6 Million - $22 Million
-141,300 Reduced 61.68%
87,800 $12.4 Million
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $21.6 Million - $27.5 Million
175,000 Added 323.48%
229,100 $35.8 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $7.59 Million - $8.79 Million
-62,300 Reduced 53.52%
54,100 $6.64 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.